高泌乳素血症:诊断和治疗的系统综述

N. Akter, N. Qureshi, T. Akter
{"title":"高泌乳素血症:诊断和治疗的系统综述","authors":"N. Akter, N. Qureshi, T. Akter","doi":"10.3329/DMCJ.V6I2.38219","DOIUrl":null,"url":null,"abstract":"Hyperprolactinemia is a common endocrine disorder that can be associated with significant morbidity. It can result from a number of causes, including use of medication, hypothyroidism and pituitary disorders. Depending on the cause and consequences of hyperprolactinemia, selected patients require treatment considering the underlying cause, age sex, and reproductive status. We describe a systematic review of hyperprolactinemia, including microadenomas and macroadenomas, in various clinical settings, with emphasis on newer diagnostic strategies and the role of various therapeutic options, including treatment with selective dopamine agonists. Through this review, we aimed to compare efficacy and adverse effects of medications, surgery and radiotherapy in the treatment of hyperprolactinemia.Delta Med Col J. Jan 2018 6(2): 90-101","PeriodicalId":53280,"journal":{"name":"Delta Medical College Journal","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3329/DMCJ.V6I2.38219","citationCount":"4","resultStr":"{\"title\":\"Hyperprolactinemia: A Systematic Review of Diagnosis and Management\",\"authors\":\"N. Akter, N. Qureshi, T. Akter\",\"doi\":\"10.3329/DMCJ.V6I2.38219\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Hyperprolactinemia is a common endocrine disorder that can be associated with significant morbidity. It can result from a number of causes, including use of medication, hypothyroidism and pituitary disorders. Depending on the cause and consequences of hyperprolactinemia, selected patients require treatment considering the underlying cause, age sex, and reproductive status. We describe a systematic review of hyperprolactinemia, including microadenomas and macroadenomas, in various clinical settings, with emphasis on newer diagnostic strategies and the role of various therapeutic options, including treatment with selective dopamine agonists. Through this review, we aimed to compare efficacy and adverse effects of medications, surgery and radiotherapy in the treatment of hyperprolactinemia.Delta Med Col J. Jan 2018 6(2): 90-101\",\"PeriodicalId\":53280,\"journal\":{\"name\":\"Delta Medical College Journal\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-09-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.3329/DMCJ.V6I2.38219\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Delta Medical College Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3329/DMCJ.V6I2.38219\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Delta Medical College Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3329/DMCJ.V6I2.38219","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

摘要

高泌乳素血症是一种常见的内分泌紊乱,可能与严重的发病率有关。它可能由多种原因引起,包括药物使用、甲状腺功能减退和垂体功能紊乱。根据高泌乳素血症的原因和后果,选定的患者需要根据潜在原因、年龄、性别和生殖状况进行治疗。我们描述了在各种临床环境中对高泌乳素血症(包括微腺瘤和大腺瘤)的系统综述,重点是新的诊断策略和各种治疗选择的作用,包括选择性多巴胺激动剂的治疗。通过这篇综述,我们旨在比较药物、手术和放疗治疗高泌乳素血症的疗效和不良反应。德尔塔医学杂志2018年1月6(2):90-101
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Hyperprolactinemia: A Systematic Review of Diagnosis and Management
Hyperprolactinemia is a common endocrine disorder that can be associated with significant morbidity. It can result from a number of causes, including use of medication, hypothyroidism and pituitary disorders. Depending on the cause and consequences of hyperprolactinemia, selected patients require treatment considering the underlying cause, age sex, and reproductive status. We describe a systematic review of hyperprolactinemia, including microadenomas and macroadenomas, in various clinical settings, with emphasis on newer diagnostic strategies and the role of various therapeutic options, including treatment with selective dopamine agonists. Through this review, we aimed to compare efficacy and adverse effects of medications, surgery and radiotherapy in the treatment of hyperprolactinemia.Delta Med Col J. Jan 2018 6(2): 90-101
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
10
审稿时长
20 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信